References
- Abou Eleinen R, Amr M, El-Gilany A, El-Mogy A, Fathi W.(2014). Substance abuse and dependence among patients attending Mansoura emergency hospital in eastern Nile delta, Egypt. Journal of Psychiatry17: 532–537.
- Adams EH, Breine S, Cicero TJ, Geller A. (2006). A comparison of abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage31(5): 465–476.
- American Psychiatric Association (APA) (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). Washington, DC: American Psychiatric Publishing, Inc. [Last accessed on 2013, Jul 1]. Available from: http://www.psychiatry.org/practice/dsm/dsm-history-of-the-manual.10.1176/appi.books.9780890425596
- Atici S, Cinel I, Cinel L. (2005). Liver and kidney toxicity in chronic use of opioids: An experimental long term treatment model. J. Biosci5(13): 30245–30252.
- Auernhammer CJ, Renner U, Muller OA. (1993). Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro. Neuroendocrinology57(6): 1019–1027.
- Chan S, Debono M, Rolfe C. (2011). Tramadol-induced Adrenal Insufficiency. Endocrine Abstracts25: 84.
- Bassiony M. (2013). Substance use disorders in Saudi Arabia. J Subst Use9(6): 450–466.
- Daniell HW. (2002). Hypogonadism in men consuming sustained-action oral opioids. J Pain3(5): 377–384
- Das G. (2014). Chronic Heroin Dependence Leading to Adrenal Insufficiency. Case Rep Endocrinol4(6): 181–183.
- De Micheli D, Lucia M, Formigoni OS. (2002). Are reasons for the first use of drugs and family circumstances predictors of future use patterns? Addict Behave27(1): 87–100.10.1016/S0306-4603(00)00167-2
- Deer TR, Gunn J. (2015). Blood testing in chronic pain management. Pain Physician18(2): 157–161.
- Deering D, Sellman D, Adamson S, Campbell S, Sheridan J, Pooley S, Robertson R, Henderson C. (2008). Opioid Dependence in New Zealand – A report for the Ministry of Health. National Addiction Centre, Otago University.
- Eassa BI, El-Shazly MA. (2012). Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation. Asian J Androl3: 12–14.
- El-Gaafarawi II. (2006). Biochemical Toxicity Induced By Tramadol Administration In Male Rats. EJHM23: 353–362.
- El-Ghawet H. (2015). Effects of tramadol on the reproductive function of wi-star albino rats, Zoology Dept, Faculty of Science, Mansoura University, Egypt. Eur J Exp Biol5(1): 56–64.
- Feldman HA, Goldstein I, Hatzichristou DG. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol151: 54–61.
- Frantz AG, Kleinberg DL, Noel GL. (1997). Studies on prolactin in man. Recent Prog Horm Res6: 527–528.
- Geng-Chang Y, Ming-Thau S, Chia-Lin Y, Ya-Wen W, Cheng-Hsiung L. (1999). High-performance liquid chromatographic method for determination of tramadol in human plasma. J Chromatogr723: 247–253.
- Goda AS. (2013). Study of oxidative factors and DNA damage in tramadol addicts. M.D Thesis (clin. Toxicology). Faculty of medicine, Cairo University. Egypt.
- Goodyear-Smith F, Gohns A, Butler R, Sheridan J, Wheeler A. (2008). Metha-done Maintenance Treatment: Barriers to, and incentives for, the transfer of opioid dependent people from secondary care to primary health care. Drug Alcohol Rev27(2): 178–184.
- Gowing LR, Ali RL, White JM. (2000). Management of opioid withdrawal. Aust N Z J Public Health24(4): 427–431.
- Hamdi E, Gawad T, Khoweiled A. (2013). Lifetime Prevalence of Alcohol and Substance Use in Egypt: A Community Survey. Substance Abuse34(2): 97–104.
- Hatzimouratidis K. (2007). Epidemiology of male sexual dysfunction. Am J Mens Health1(2): 103–25.
- Herzog AG, Drislane FW, Schomer DL, Pennell PB. (2004). Differntial effects of tramadol on sexual function and reproductive hormones in men. Horm. Behav45(7): 764–768.
- International Narcotics Control Board Report (INCB). (2013). Analysis Of The World Situation. United Nations Publication. ch 3. (www.incb.org).
- Kaminetsky J. (2008). Epidemiology and pathophysiology of male sexual dysfunction. Int J Impot Res20: S3–S10.
- Katz M, Nathaniel D, Mazer M, Norman A. (2009). The Impact of Opioids on the Endocrine System. Clin. J. Pain25(2): 170–175.
- Marquardt KA, Alsopm JA, Albertson TE. (2005). Tramadol exposures reported to statewide poison control system. Ann. Pharmacother.J39(6): 1039–1044.
- Mc Elhaney KB, Antonishak J, Allen JP. (2008). They like me, they like me not: Popularity and adolescents’ perceptions of acceptance predicting social functioning over time. Child Dev79(3): 720–731.
- Mckim WA. (2003). Drug and behavior, an introduction to behavioral pharmacology. Prentice Hall, New Jersey, 5th ed., p.243.
- Monahan K, Egan EA, Van Horn M. (2011). Community-level effects of individual and peer risk and protective factors on adolescent substance use. J Community Psychol39(4): 478–498.
- Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. (2004). Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology64: 991–997.
- Rebecca E, Schane RE, Pamela M, Ling PM, Stanto A, Glant SA. (2010). Health Effects of Light and Intermittent Smoking. Am Heart Assoc121: 1518–1522.
- Oshodi OY, Aina OF, Onajole AT. (2010). Substance use among secondary school students in an urban setting in Nigeria: prevalence and associated factors. Afr J Psychiatry13: 52–57.
- Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleve MA. (2008). Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med5: 188–193.
- Shipton EA. (2000). Tramadol-present and future. Anaesthesia. Intensive Care28(4): 363–374.
- Solarino B, Riesselmann B, Buschmann CT, Sokos M. (2010). Multidrug poisoning involving nicotine and tramadol. Forensic Sci. Int194(1–3): 17–19.
- Tashakori A, Afshari R. (2010). Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol48(4): 337–341.
- Travison TG, Araujo AB, O〉Donnell AB, Kupelian V, McKinlay JB. (2007). A population-level decline in serum testosterone levels in men. J Clin Endocrinol Metab92(1): 196–202.
- Vorsanger GJ, Xiang J, Gana TJ, Pascua ML, Fleming R. (2008). Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag4(2): 87–97.